Patents by Inventor Eric Thomas Hurst

Eric Thomas Hurst has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12663916
    Abstract: A method for designing a cell-based screening assay experiment includes, at a graphical user interface, receiving a first input identifying a template plate definition and receiving a second input defining a first group of disease reagents and at least one destination concentration of the disease reagents. The method also includes receiving a third input defining a first group of treatment reagents, at least one destination concentration for the treatment reagents, a number of replicates of the treatment reagents, and a selection to associate the first group of treatment reagents with the first group of disease reagents. The method further includes generating, based at least partially on the inputs, a design for the cell-based screening assay experiment, including determining a number of test wells required for performing the experiment, and distributing the test wells over a one or more test plates that are instances of the template plate definition.
    Type: Grant
    Filed: April 19, 2024
    Date of Patent: June 23, 2026
    Assignee: Recursion Pharmaceuticals, Inc.
    Inventors: Adam Smith Murray, Anthus John Williams, Benjamin Judson Sukow, Brian James Bleakley, Chadwick Thelen Davis, Condie Thomas Swallow, II, Daniel James Anderson, Eric Thomas Hurst, Jathine Wong, Katherine Bowie Matsumoto Santos, Katrina Stacie Rodzon, Kristen Rose Morse, Peter Foster McLean, Teresa Kay Anderson-Myers
  • Patent number: 12395408
    Abstract: The present disclosure relates to systems, non-transitory computer-readable media, and methods that implement an orchestration interface for managing and operating complex compound discovery pipelines across computer networks. Indeed, in one or more implementations, the disclosed systems manage and operate a compound discovery event publication repository for collecting and publishing events from various devices of different stages within the compound discovery pipeline according to a flexible event schema. To illustrate, utilizing the disclosed systems, individual devices can define and publish events with corresponding relationships (e.g., dependencies, parent-child relationships) for consumption and utilization by other group devices in a manner that provides flexibility to individual devices while coordinating accurately with downstream computer processes.
    Type: Grant
    Filed: November 30, 2023
    Date of Patent: August 19, 2025
    Assignee: Recursion Pharmaceuticals, Inc.
    Inventors: Anthus John Williams, Brandon Wayne Nichols, Eric Thomas Hurst, Justin Wade Needham, Matthew Michael Burbidge, Matthew Lowry McKeithen